title: [Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer].
abstract: The established standard treatment for advanced ovarian cancer is carboplatin and paclitaxel. However, more than 70% of patients have recurrent disease. The standard therapy for recurrent ovarian cancer has not been confirmed. It was reported that docetaxel had a 30-40% of response rate in patients with recurrent ovarian cancer, and that gemcitabine had a 13-22% response rate. The combination chemotherapy of gemcitabine and docetaxel is also applied to non-small cell lung cancer. We use a regimen of 800 mg/m2 of gemcitabine on day 1 and day 8 in combination with 70 mg/m2 of docetaxel on day 8 with a 3-week interval. We treated 2 patients with recurrent ovarian cancer who responded completely to combination chemotherapy with gemcitabine and docetaxel.
authors.affiliation: Dept. of Obstetrics and Gynecology, Kansai Rosai Hospital.
authors.forename: Kimihiko
authors.initials: K
authors.lastname: Ito
authors.forename: Susumu
authors.initials: S
authors.lastname: Adachi
authors.forename: Takashi
authors.initials: T
authors.lastname: Iijima
authors.forename: Yuki
authors.initials: Y
authors.lastname: Nakatsuji
authors.forename: Toshio
authors.initials: T
authors.lastname: Kimura
authors.forename: Toshikatu
authors.initials: T
authors.lastname: Nobunaga
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018269:Carcinoma, Endometrioid / Q000188:drug therapy* / Q000556:secondary; D018284:Cystadenocarcinoma, Serous / Q000188:drug therapy* / Q000556:secondary; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077143:Docetaxel; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010386:Pelvic Neoplasms / Q000556:secondary*; D043823:Taxoids; D000093542:Gemcitabine
chemical_list: D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D017239:Paclitaxel; D000093542:Gemcitabine